123 related articles for article (PubMed ID: 33636231)
1. Determining the incidence of interstitial pneumonitis and chronic kidney disease following full intensity haemopoetic stem cell transplant conditioned using a forward-planned intensity modulated total body irradiation technique.
Durie E; Nicholson E; Anthias C; Dunne EM; Potter M; Ethell M; Messiou C; Brennan J; Eagle S; Talbot J; Smyth G; Ingram W; Saran F; Mandeville HC
Radiother Oncol; 2021 May; 158():97-103. PubMed ID: 33636231
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of allogeneic haematopoietic stem cell transplantation with intensity-modulated total body irradiation by helical tomotherapy: a 2-year prospective follow-up study.
Konishi T; Ogawa H; Najima Y; Hashimoto S; Kito S; Atsuta Y; Wada A; Adachi H; Konuma R; Kishida Y; Nagata A; Yamada Y; Kaito S; Mukae J; Marumo A; Noguchi Y; Shingai N; Toya T; Igarashi A; Shimizu H; Kobayashi T; Ohashi K; Doki N; Murofushi KN
Ann Med; 2022 Dec; 54(1):2616-2625. PubMed ID: 36254468
[TBL] [Abstract][Full Text] [Related]
3. Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation.
Ozsahin M; Belkacémi Y; Pène F; Laporte J; Rio B; Leblond V; Korbas D; Touboul E; Gorin NC; Schlienger M; Laugier A
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):71-7. PubMed ID: 12118567
[TBL] [Abstract][Full Text] [Related]
4. Higher Total Body Irradiation Dose Intensity in Fludarabine/TBI-Based Reduced-Intensity Conditioning Regimen Is Associated with Inferior Survival in Non-Hodgkin Lymphoma Patients Undergoing Allogeneic Transplantation.
Hamadani M; Khanal M; Ahn KW; Litovich C; Chow VA; Eghtedar A; Karmali R; Winter A; Fenske TS; Sauter C; Kharfan-Dabaja MA; Awan FT
Biol Blood Marrow Transplant; 2020 Jun; 26(6):1099-1105. PubMed ID: 32165327
[TBL] [Abstract][Full Text] [Related]
5. 20 years of experience in static intensity-modulated total-body irradiation and lung toxicity. Results in 257 consecutive patients.
Schneider RA; Schultze J; Jensen JM; Hebbinghaus D; Galalae R; Kimmig BN
Strahlenther Onkol; 2007 Oct; 183(10):545-51. PubMed ID: 17896085
[TBL] [Abstract][Full Text] [Related]
6. Safety of total body irradiation using intensity-modulated radiation therapy by helical tomotherapy in allogeneic hematopoietic stem cell transplantation: a prospective pilot study.
Konishi T; Ogawa H; Najima Y; Hashimoto S; Wada A; Adachi H; Konuma R; Kishida Y; Nagata A; Yamada Y; Kaito S; Mukae J; Marumo A; Noguchi Y; Toya T; Igarashi A; Kobayashi T; Ohashi K; Doki N; Karasawa K
J Radiat Res; 2020 Nov; 61(6):969-976. PubMed ID: 32888029
[TBL] [Abstract][Full Text] [Related]
7. [Second allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and donor changes in relapsed hematological malignancies after the first allogeneic transplant].
Zhao YQ; Song YZ; Li ZH; Yang F; Xu T; Li FF; Yang DF; Wu T
Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):465-471. PubMed ID: 37550201
[No Abstract] [Full Text] [Related]
8. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial.
Sandmaier BM; Kornblit B; Storer BE; Olesen G; Maris MB; Langston AA; Gutman JA; Petersen SL; Chauncey TR; Bethge WA; Pulsipher MA; Woolfrey AE; Mielcarek M; Martin PJ; Appelbaum FR; Flowers MED; Maloney DG; Storb R
Lancet Haematol; 2019 Aug; 6(8):e409-e418. PubMed ID: 31248843
[TBL] [Abstract][Full Text] [Related]
9. Reduced incidence of interstitial pneumonitis after allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation.
Chiang Y; Tsai CH; Kuo SH; Liu CY; Yao M; Li CC; Huang SY; Ko BS; Lin CT; Hou HA; Chou WC; Liu JH; Lin CC; Wu SJ; Hsu SC; Chen YC; Lin KH; Lin DT; Chou HT; Lu MY; Yang YL; Chang HH; Liu MC; Liao XW; Wu JK; Chou SC; Cheng CL; Chen CY; Tsay W; Tien HF; Tang JL; Chen YH
Sci Rep; 2016 Nov; 6():36730. PubMed ID: 27830767
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of TBI+rATG-based conditioning regimen for haploidentical allogeneic hematopoietic stem cell transplantation in 11 cases of chemotherapy-resistant advanced peripheral T-cell lymphoma].
Xu R; Li S; Liu HX; Wei DL; Jiang Y; Wang JJ; Liu SS; Wang C; Zhu J
Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):578-581. PubMed ID: 37749039
[No Abstract] [Full Text] [Related]
11. Analysis of long-term mortality after total body irradiation-based and melphalan-based chemotherapy conditioning for acute myeloid leukemia.
Gruber I; Koelbl O; Treutwein M; Zeman F; Herr W; Holler E; Edinger M; Wolff D
Ann Hematol; 2023 Aug; 102(8):2199-2211. PubMed ID: 37347269
[TBL] [Abstract][Full Text] [Related]
12. Clofarabine and total body irradiation (TBI) as conditioning regimen for allogeneic stem cell transplantation in high-risk acute leukemia patients: a two-center retrospective cohort study.
El Cheikh J; Bidaoui G; Atoui A; Terro K; Sharrouf L; Zahreddine A; Moukalled N; Abou Dalle I; Bazarbachi A; Mohty M; Dulery R
Bone Marrow Transplant; 2023 Jun; 58(6):667-672. PubMed ID: 36914730
[TBL] [Abstract][Full Text] [Related]
13. Lethal pulmonary toxicity after autologous bone marrow transplantation/peripheral blood stem cell transplantation for hematological malignancies.
Lohr F; Wenz F; Schraube P; Flentje M; Haas R; Zierhut D; Fehrentz D; Hunstein W; Wannenmacher M
Radiother Oncol; 1998 Jul; 48(1):45-51. PubMed ID: 9756171
[TBL] [Abstract][Full Text] [Related]
14. Influence of radiation dose rate and lung dose on interstitial pneumonitis after fractionated total body irradiation: acute parotitis may predict interstitial pneumonitis.
Oya N; Sasai K; Tachiiri S; Sakamoto T; Nagata Y; Okada T; Yano S; Ishikawa T; Uchiyama T; Hiraoka M
Int J Hematol; 2006 Jan; 83(1):86-91. PubMed ID: 16443559
[TBL] [Abstract][Full Text] [Related]
15. A comparison of single-dose and fractionated total-body irradiation on the development of pneumonitis following bone marrow transplantation.
Morgan TL; Falk PM; Kogut N; Shah KH; Tome M; Kagan AR
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):61-6. PubMed ID: 8823259
[TBL] [Abstract][Full Text] [Related]
16. Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission. Results and prognostic factors in 326 consecutive patients.
Belkacémi Y; Pène F; Touboul E; Rio B; Leblond V; Gorin NC; Laugier A; Gemici C; Housset M; Ozsahin M
Strahlenther Onkol; 1998 Feb; 174(2):92-104. PubMed ID: 9487372
[TBL] [Abstract][Full Text] [Related]
17. Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.
Piñana JL; Valcárcel D; Martino R; Barba P; Moreno E; Sureda A; Vega M; Delgado J; Briones J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2009 Jan; 15(1):21-9. PubMed ID: 19135939
[TBL] [Abstract][Full Text] [Related]
18. Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Nath K; Peterson K; Brown S; Devlin S; Rodriguez N; Barker J; Giralt S; Gyurkocza B; Jakubowski A; Papadopoulos E; Ponce D; Scordo M; Shah G; Perales MA; Sauter C; Lin A; Dahi PB
Transplant Cell Ther; 2024 Jan; 30(1):81-92. PubMed ID: 37788792
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome after static intensity-modulated total body radiotherapy using compensators stratified by pediatric and adult cohorts.
Schneider RA; Schultze J; Jensen JM; Hebbinghaus D; Galalae RM
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):194-202. PubMed ID: 17869024
[TBL] [Abstract][Full Text] [Related]
20. Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Jeon YW; Yoon S; Min GJ; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Cho SG
Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):345-355.e7. PubMed ID: 31014757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
